raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:398127

Neonatal scleroderma

Type
Disease
Group
Disorder
Inheritance
Not applicable
Age of onset
Neonatal
Status
active

A rare secondary neonatal autoimmune disease characterized by neonatal-onset of erythematous skin lesions with a linear appearance that gradually become indurated and hyperpigmented and progressively present skin atrophy. Positive serum antibodies (in particular antinuclear antibodies and/or rheumatoid factor) may be associated.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enNeonatal scleroderma
frSclérodermie néonatale
deNeonatale Sklerodermie
esEscleroderma neonatal
itSclerodermia neonatale
nlNeonatale sclerodermie
ptEsclerodermia neonatal
plTwardzina noworodków
csNeonatální sklerodermie
ukНеонатальна склеродермія
zh新生儿硬皮病
trYenidoğan skleroderması

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
ICD-10P83.8NTBTinclusionvalidated
ICD-11KC22.2NTBTattributedvalidated
MONDO0018361Evalidated
UMLSC4509425Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

0 direct

Orphanet records no gene directly on this code.

5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families6 casesWorldwideCase(s)Validated16887444[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_16887444[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card